Mechanisms of liver disease: Cross-talk between the NF-κB and JNK pathways

Biological Chemistry

Volumn 390, Issue 10, 2009, Pages 965-976

  Papa, Salvatore ^a   Bubici, Concetta ^a   Zazzeroni, Francesca ^b   Franzoso, Guido ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

Gadd45 ; Hepatocellular carcinoma; Liver injury; Liver regeneration; Programmed cell death; TNF

Indexed keywords

CASPASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA;

CELL SURVIVAL; CYTOKINE PRODUCTION; EMBRYO DEVELOPMENT; HEPATITIS; HUMAN; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER CELL DAMAGE; LIVER DEVELOPMENT; LIVER DISEASE; LIVER FUNCTION; LIVER INJURY; LIVER NECROSIS; LIVER PROTECTION; LIVER REGENERATION; LIVER TOXICITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL PHYSIOLOGICAL PROCESSES; HEPATITIS; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LIVER DISEASES; NF-KAPPA B; SIGNAL TRANSDUCTION;

EID: 70349308534     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/BC.2009.111     Document Type: Review

References (85)

1. Abshagen, K., Eipel, C., Kalff, J.C., Menger, M.D., and Vollmar, B. (2007). Loss of NF-kB activation in Kupffer cell-depleted mice impairs liver regeneration after partial hepatectomy. Am. J. Physiol. Gastrointest. Liver Physiol. 292, G1570-G1577.
2. Akerman, P.A., Cote, P., Yang, S.Q., McClain, C., Nelson, S., Bagby, G.J., and Diehl, A.M. (1992). Antibodies to tumor necrosis factor-a inhibit liver regeneration after partial hepa-tectomy. Am. J. Physiol. 263, G579-G585.
3. Amanullah, A., Azam, N., Balliet, A., Hollander, C., Hoffman, B., Fornace, A., and Liebermann, D. (2003). Cell signaling: cell survival and a Gadd45-factor deficiency. Nature 424, 741; discussion 742.
4. Antoine, D.J., Williams, D.P., and Park, B.K. (2008). Understanding the role of reactive metabolites in drug-induced hepato-toxicity: state of the science. Expert Opin. Drug. Metab. Toxicol. 4, 1415-1427.
5. Beg, A.A. and Baltimore, D. (1996). An essential role for NF-kB in preventing TNF-a-induced cell death. Science 274, 782-784.
6. Beg, A.A., Sha, W.C., Bronson, R.T., Ghosh, S., and Baltimore, D. (1995). Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kB. Nature 376, 167-170.
7. Beutler, B., Mahoney, J., Le Trang, N., Pekala, P., and Cerami, A. (1985). Purification of cachectin, a lipoprotein lipase-sup-pressing hormone secreted by endotoxin-induced RAW 264.7 cells. J. Exp. Med. 161, 984-995.
8. Boya, P., Larrea, E., Sola, I., Majano, P.L., Jiménez, C., Civeira, M.P., and Prieto, J. (2001). Nuclear factor-kB in the liver of patients with chronic hepatitis C: decreased RelA expression is associated with enhanced fibrosis progression. Hepatolo-gy 34, 1041-1048.
9. Bubici, C., Papa, S., Dean, K., and Franzoso, G. (2006). Mutual crosstalk between reactive oxygen species and nuclear factor-kB: molecular basis and biological significance. Onco-gene 25, 6731-6748.
10. Cayama, E., Tsuda, H., Sarma, D.S., and Farber, E. (1978) Initiation of chemical carcinogenesis requires cell proliferation. Nature 275, 60-62.
11. Chaisson, M.L., Brooling, J.T., Ladiges, W., Tsai, S., and Fausto, N. (2002). Hepatocyte-specific inhibition of NF-kB leads to apoptosis after TNFa-treatment, but not after partial hepa-tectomy. J. Clin. Invest. 110, 193-202.
12. Chang, L., Kamata, H., Solinas, G., Luo, J.L., Maeda, S., Venu-prasad, K., Liu, Y.C., and Karin, M. (2006). The E3 ubiquitin ligase itch couples JNK activation to TNFa-induced cell death by inducing c-FLIP(L) turnover. Cell 124, 601-613.
13. Cressman, D.E., Greenbaum, L.E., Haber, B.A., and Taub, R. (1994). Rapid activation of post-hepatectomy factor/nuclear factor kB in hepatocytes, a primary response in the regenerating liver. J. Biol. Chem. 269, 30429-30435.
14. Das, M., Sabio, G., Jiang, F., Rincón, M., Flavell, R.A., and Davis, R.J. (2009). Induction of hepatitis by JNK-mediated expression of TNF-a. Cell 136, 249-260.
15. Davis, R.J. (2000). Signal transduction by the JNK group of MAP kinases. Cell 103, 239-252.
16. De Smaele, E., Zazzeroni, F., Papa, S., Nguyen, D.U., Jin, R., Jones, J., Cong, R., and Franzoso, G. (2001). Induction of gadd45b by NF-kB downregulates pro-apoptotic JNK signaling. Nature 414, 308-313.
17. Deng, Y., Ren, X., Yang, L., Lin, Y., and Wu, X. (2003). A JNK-dependent pathway is required for TNFa-induced apoptosis. Cell 115, 61-70.
18. Dutta, J., Fan, Y., Gupta, N., Fan, G., and Gélinas, C. (2006). Current insights into the regulation of programmed cell death by NF-kB. Oncogene 25, 6800-6816.
19. Evan, G.I., Brown, L., Whyte, M., and Harrington, E. (1995). Apoptosis and the cell cycle. Curr. Opin. Cell. Biol. 7, 825-834.
20. Fausto, N., Campbell, J.S., and Riehle, K.J. (2006). Liver regeneration. Hepatology 43, S45-S53.
21. Geisler, F., Algül, H., Paxian, S., and Schmid, R.M. (2007). Genetic inactivation of RelA/p65 sensitizes adult mouse hepato-cytes to TNF-induced apoptosis in vivo and in vitro. Gastroenterology 132, 2489-2503
22. González-Amaro, R., García-Monzón, C., García-Buey, L., More-no-Otero, R., Alonso, J.L., Yagüe, E., Pivel, J.P., López-Cabrera, M., Fernández-Ruiz, E., and Sánchez-Madrid, F. (1994). Induction of tumor necrosis factor a production by human hepatocytes in chronic viral hepatitis. J. Exp. Med. 179, 841-848.
23. Guicciardi, M.E. and Gores, G.J. (2005). Apoptosis: a mechanism of acute and chronic liver injury. Gut 54, 1024-1033.
24. Hayden, M.S. and Ghosh, S. (2004). Signaling to NF-kB. Genes Dev. 18, 2195-2224.
25. Heinrichsdorff, J., Luedde, T., Perdiguero, E., Nebreda, A.R., and Pasparakis, M. (2008). p38a MAPK inhibits JNK activation and collaborates with IkB kinase 2 to prevent endotoxin-induced liver failure. EMBO Rep. 9, 1048-1054.
26. Higuchi, H. and Gores, G.J. (2003). Bile acid regulation of hepatic physiology. IV. Bile acids and death receptors. Am. J. Phy-siol. Gastrointest. Liver Physiol. 284, G734-G738.
27. Hill, D.B. and McClain, C.J. (2004). Anti-TNF therapy in alcoholic hepatitis. Am. J. Gastroenterol. 99, 261-263.
28. Hui, L., Zatloukal, K., Scheuch, H., Stepniak, E., Wagner, E.F. (2008). Proliferation of human HCC cells and chemically induced mouse liver cancers requires JNK1-dependent p21 downregulation. J. Clin. Invest. 118, 3943-3953.
29. Hussain, S.P. and Harris, C.C. (2007). Inflammation and cancer: an ancient link with novel potentials. Int. J. Cancer 121, 2373-2380.
30. Iimuro, Y., Nishiura, T., Hellerbrand, C., Behrns, K.E., Schoon-hoven, R., Grisham, J.W., and Brenner, D.A. (1998). NF-kB prevents apoptosis and liver dysfunction during liver regeneration. J. Clin. Invest. 101, 802-811.
31. Ioannides, C., ed. (2008). Cytochromes P450: Role in the Metabolism and Toxicity of Drugs and other Xenobiotics (Cambridge, UK: RSC Publishing).
32. Johnson, G.L. and Lapadat, R. (2002). Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298, 1911-1912.
33. Kamata, H., Honda, S., Maeda, S., Chang, L., Hirata, H., and Karin, M. (2005). Reactive oxygen species promote TNFa-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell 120, 649-661.
34. Karin, M. (2006). Nuclear factor-kB in cancer development and progression. Nature 441, 431-436.
35. Karin, M. and Gallagher, E. (2005). From JNK to pay dirt: Jun kinases, their biochemistry, physiology and clinical importance. IUBMB Life 57, 283-295.
36. Kaufmann, T., Jost, P.J., Pellegrini, M., Puthalakath, H., Guga-syan, R., Gerondakis, S., Cretney, E., Smyth, M.J., Silke, J., Hakem, R., et al. (2009). Fatal hepatitis mediated by tumor necrosis factor TNFa requires caspase-8 and involves the BH3-only proteins Bid and Bim. Immunity 30, 56-66.
37. Koch, K.S., Maeda, S., He, G., Karin, M., and Leffert, H.L. (2009). Targeted deletion of hepatocyte IKKb confers growth advantages. Biochem. Biophys. Res. Commun. 380, 349-354.
38. Kodama, Y., Taura, K., Miura, K., Schnabl, B., Osawa, Y., and Brenner, D.A. (2009). Anti-apoptotic effect of c-Jun N-termi-nal Kinase-1 through Mcl-1 stabilization in TNF-induced hepatocyte apoptosis. Gastroenterology 136, 1423-1434.
39. Kushner, I. (1982). The phenomenon of the acute phase response. Ann. NY Acad. Sci. 389, 39-48.
40. Li, Q., Van Antwerp, D., Mercurio, F., Lee, K.F., and Verma, I.M. (1999a). Severe liver degeneration in mice lacking the IkB kinase 2 gene. Science 284, 321-325.
41. Li, Z.W., Chu, W., Hu, Y., Delhase, M., Deerinck, T., Ellisman, M., Johnson, R., and Karin, M. (1999b). The IKKb subunit of IkB kinase (IKK) is essential for nuclear factor kB activation and prevention of apoptosis. J. Exp. Med. 189, 1839-1845.
42. Lim, I.K. (2002). Spectrum of molecular changes during hepa-tocarcinogenesis induced by DEN and other chemicals in Fischer 344 male rats. Mech. Ageing Dev. 123, 1665-1680.
43. Luedde, T., Assmus, U., Wüstefeld, T., Meyer zu Vilsendorf, A., Roskams, T., Schmidt-Supprian, M., Rajewsky, K., Brenner, D.A., Manns, M.P., Pasparakis, M., et al. (2005). Deletion of IKK2 in hepatocytes does not sensitize these cells to TNF-induced apoptosis but protects from ischemia/reperfusion injury. J. Clin. Invest. 115, 849-859.
44. Luedde, T., Beraza, N., Kotsikoris, V., van Loo, G., Nenci, A., De Vos, R., Roskams, T., Trautwein, C., and Pasparakis, M. (2007). Deletion of NEMO/IKKg in liver parenchymal cells causes steatohepatitis and hepatocellular carcinoma. Cancer Cell 11, 119-132.
45. Maeda, S., Chang, L., Li, Z.W., Luo, J.L., Leffert, H., and Karin, M. (2003). IKKb is required for prevention of apoptosis mediated by cell-bound but not by circulating TNFa. Immunity 19, 725-737.
46. Maeda, S., Kamata, H., Luo, J.L., Leffert, H., and Karin, M. (2005). IKKb couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepato-carcinogenesis. Cell 121, 977-990.
47. Makris, C., Godfrey, V.L., Krähn-Senftleben, G., Takahashi, T., Roberts, J.L., Schwarz, T., Feng, L., Johnson, R.S., and Karin, M. (2000). Female mice heterozygous for IKKg/NEMO deficiencies develop a dermatopathy similar to the human X-linked disorder incontinentia pigmenti. Mol. Cell 5, 969-979.
48. Malato, Y., Sander, L.E., Liedtke, C., Al-Masaoudi, M., Tacke, F., Trautwein, C., and Beraza, N. (2008). Hepatocyte-specific inhibitor-of-kB-kinase deletion triggers the innate immune response and promotes earlier cell proliferation during liver regeneration. Hepatology 47, 2036-2050.
49. Malhi, H. and Gores, G.J. (2008). Cellular and molecular mechanisms of liver injury. Gastroenterology 134, 1641-1654.
50. Matsuzawa, A. and Ichijo, H. (2008). Redox control of cell fate by MAP kinase: physiological roles of ASK1-MAP kinase pathway in stress signaling. Biochim. Biophys. Acta 1780, 1325-1336.
51. Mauad, T.H., van Nieuwkerk, C.M., Dingemans, K.P., Smit, J.J.M., Schinkel, A.H., Notenboom, R.G.E., van den Bergh Weerman, M.A., Verkruisen, R.P., Groen, A.K., Oude Elferink, R.P., et al. (1994). Mice with homozygous disruption of the mdr2 P-glycoprotein gene. A novel animal model for studies of nonsuppurative inflammatory cholangitis and hepatocar-cinogenesis. Am. J. Pathol. 145, 1237-1245.
52. Michalopoulos, G.K. (2007). Liver regeneration. J. Cell. Physiol. 213, 286-300.
53. Ni, H.M., Chen, X., Shi, Y.H., Liao, Y., Beg, A.A., Fan, J., and Yin, X.M. (2009). Genetic delineation of the pathways mediated by bid and JNK in tumor necrosis factor-a-induced liver injury in adult and embryonic mice. J. Biol. Chem. 284, 4373-4382.
54. Papa, S., Zazzeroni, F., Pham, C.G., Bubici, C., and Franzoso, G. (2004a). Linking JNK signaling to NF-kB: a key to survival. J. Cell. Sci. 117, 5197-5208.
55. Papa, S., Zazzeroni, F., Bubici, C., Jayawardena, S., Alvarez, K., Matsuda, S., Nguyen, D.U., Pham, C.G., Nelsbach, A.H., Melis, T., et al. (2004b). Gadd45b mediates the NF-kB suppression of JNK signaling by targeting MKK7/JNKK2. Nat. Cell Biol. 6, 146-153.
56. Papa, S., Bubici, C., Zazzeroni, F., Pham, C.G., Kuntzen, C., Knabb, J.R., Dean, K., and Franzoso, G. (2006). The NF-kB-mediated control of the JNK cascade in the antagonism of programmed cell death in health and disease. Cell Death Differ. 13, 712-729.
57. Papa, S., Monti, S.M., Vitale, R.M., Bubici, C., Jayawardena, S., Alvarez, K., De Smaele, E., Dathan, N., Pedone, C., Ruvo, M., and Franzoso, G. (2007). Insights into the structural basis of the GADD45b-mediated inactivation of the JNK kinase, MKK7/JNKK2. J. Biol. Chem. 282, 19029-19041.
58. Papa, S., Zazzeroni, F., Fu, Y.X., Bubici, C., Alvarez, K., Dean, K., Christiansen, P.A., Anders, R.A., and Franzoso, G. (2008). Gadd45b promotes hepatocyte survival during liver regeneration in mice by modulating JNK signaling. J. Clin. Invest. 118, 1911-1923.
59. Parkinson, A. (2001). Biotransformation of xenobiotics. In: Casa-rett and Doull's Toxicology: The Basic Science of Poisons, 6th edn., C.D. Klaassen, ed. (New York, USA: McGraw-Hill), pp. 133-224.
60. Pfeffer, K., Matsuyama, T., Kündig, T.M., Wakeham, A., Kishi-hara, K., Shahinian, A., Wiegmann, K., Ohashi, P.S., Krönke, M., and Mak, T.W. (1993). Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 73, 457-467.
61. Pikarsky, E., Porat, R.M., Stein, I., Abramovitch, R., Amit, S., Kasem, S., Gutkovich-Pyest, E., Urieli-Shoval, S., Galun, E., and Ben-Neriah, Y. (2004). NF-kB functions as a tumour promoter in inflammation-associated cancer. Nature 431, 461-466.
62. Plumpe, J., Malek, N.P., Bock, C.T., Rakemann, T., Manns, M.P., and Trautwein, C. (2000). NF-kB determines between apop-tosis and proliferation in hepatocytes during liver regeneration. Am. J. Physiol. Gastrointest. Liver. Physiol. 278, G173-G183.
63. Pound, A.W., Lawson, T.A., and Horn, L. (1973). Increased carcinogenic action of dimethylnitrosamine after prior administration of carbon tetrachloride. Br. J. Cancer 27, 451-459.
64. Prusty, B.K., Hedau, S., Singh, A., Kar, P., and Das, B.C. (2007). Selective suppression of NF-kB/p65 in hepatitis virus-infected pregnant women manifesting severe liver damage and high mortality. Mol. Med. 13, 518-526.
65. Reinehr, R., Becker, S., Keitel, V., Eberle, A., Grether-Beck, S., and Haussinger, D. (2005). Bile salt-induced apoptosis involves NADPH oxidase isoform activation. Gastroenterol-ogy 129, 2009-2031.
66. Rosenfeld, M.E., Prichard, L., Shiojiri, N., and Fausto, N. (2000). Prevention of hepatic apoptosis and embryonic lethality in RelA/TNFR-1 double knockout mice. Am. J. Pathol. 156, 997-1007.
67. Sakon, S., Xue, X., Takekawa, M., Sasazuki, T., Okazaki, T., Koji-ma, Y., Piao, J.H., Yagita, H., Okumura, K., Doi, T., and Naka-no, H. (2003). NF-kB inhibits TNF-induced accumulation of ROS that mediate prolonged MAPK activation and necrotic cell death. EMBO J. 22, 3898-3909.
68. Sakurai, T., Maeda, S., Chang, L., and Karin, M. (2006). Loss of hepatic NF-kB activity enhances chemical hepatocarcino-genesis through sustained c-Jun N-terminal kinase 1 activation. Proc. Natl. Acad. Sci. USA 103, 10544-10551.
69. Sakurai, T., He, G., Matsuzawa, A., Yu, G.Y., Maeda, S., Hardi-man, G., and Karin, M. (2008). Hepatocyte necrosis induced by oxidative stress and IL-1a release mediate carcinogen-induced compensatory proliferation and liver tumorigenesis. Cancer Cell 14, 156-165.
70. Schwabe, R.F. and Brenner, D.A. (2006). Mechanisms of liver injury. I. TNF-a-induced liver injury: role of IKK, JNK, and ROS pathways. Am. J. Physiol. Gastrointest. Liver Physiol. 290, G583-G589.
71. Streetz, K., Leifeld, L., Grundmann, D., Ramakers, J., Eckert, K., Spengler, U., Brenner, D., Manns, M., and Trautwein, C. (2000). Tumor necrosis factor a in the pathogenesis of human and murine fulminant hepatic failure. Gastroenterology 119, 446-460.
72. Sun, B. and Karin, M. (2008). NF-kB signaling, liver disease and hepatoprotective agents. Oncogene 27, 6228-6244.
73. Tang, G., Minemoto, Y., Dibling, B., Purcell, N.H., Li, Z., Karin, M., and Lin, A. (2001). Inhibition of JNK activation through NF-kB target genes. Nature 414, 313-317.
74. Thorgeirsson, S.S. and Grisham, J.W. (2002). Molecular patho-genesis of human hepatocellular carcinoma. Nat. Genet. 31, 339-346.
75. Tiegs, G., Hentschel, J., and Wendel, A. (1992). A T cell-dependent experimental liver injury in mice inducible by concana-valin A. J. Clin. Invest. 90, 196-203.
76. Tsuji, H., Harada, A., Mukaida, N., Nakanuma, Y., Bluethmann, H., Kaneko, S., Yamakawa, K., Nakamura, S.I., Kobayashi, K.I., and Matsushima, K. (1997). Tumor necrosis factor receptor p55 is essential for intrahepatic granuloma formation and hepatocellular apoptosis in a murine model of bacterium-induced fulminant hepatitis. Infect. Immun. 65, 1892-1898.
77. Vainer, G.W., Pikarsky, E., and Ben-Neriah, Y. (2008). Contradictory functions of NF-kB in liver physiology and cancer. Cancer Lett. 267, 182-188.
78. Varfolomeev, E.E. and Ashkenazi, A. (2004). Tumor necrosis factor: an apoptosis JuNKie? Cell 116, 491-497.
79. Wajant, H., Pfizenmaier, K., and Scheurich, P. (2003). Tumor necrosis factor signaling. Cell Death Differ. 10, 45-65.
80. Wang, C.Y., Mayo, M.W., Korneluk, R.G., Goeddel, D.V., and Baldwin, A.S. (1998). NF-kB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress cas-pase-8 activation. Science 281, 1680-1683.
81. Wang, Y., Singh, R., Lefkowitch, J.H., Rigoli, R.M., and Czaja, M.J. (2006). Tumor necrosis factor-induced toxic liver injury results from JNK2-dependent activation of caspase-8 and the mitochondrial death pathway. J. Biol. Chem. 281, 15258-15267.
82. Wullaert, A., Heyninck, K., and Beyaert, R. (2006). Mechanisms of crosstalk between TNF-induced NF-kB and JNK activation in hepatocytes. Biochem Pharmacol. 72, 1090-1101.
83. Wullaert, A., van Loo, G., Heyninck, K., and Beyaert, R. (2007). Hepatic tumor necrosis factor signaling and nuclear factor-kB: effects on liver homeostasis and beyond. Endocr. Rev. 28, 365-386.
84. Yamada, Y., Kirillova, I., Peschon, J.J., and Fausto, N. (1997). Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor. Proc. Natl. Acad. Sci. USA 94, 1441-1446.
85. Yau, T.O., Chan, C.F., Gee-San Lam, S., Cheung, O.F., Ching, Y.P., Jin, D.Y., Sham, M.H., and Ng, I.O. (2009). Hepatocyte-specific activation of NF-kB does not aggravate chemical hepatocarcinogenesis in transgenic mice. J. Pathol. 217, 353-361.